Cardinal Health Inc. (CAH) News

Cardinal Health Inc. (CAH): $107.14

0.32 (-0.30%)

POWR Rating

Component Grades








Add CAH to Watchlist
Sign Up

Industry: Medical - Services




#2 of 65

in industry

Filter CAH News Items

CAH News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

CAH News Highlights

  • For CAH, its 30 day story count is now at 20.
  • Over the past 16 days, CAH's stories per day has been in a clear uptrend, growing by about 0.13 per day.
  • CBOE, SAFE and AEO are the most mentioned tickers in articles about CAH.

Latest CAH News From Around the Web

Below are the latest news stories about CARDINAL HEALTH INC that investors may wish to consider to help them evaluate CAH as an investment opportunity.

Are Medical Stocks Lagging Arch Therapeutics (ARTH) This Year?

Here is how Arch Therapeutics, Inc. (ARTH) and Cardinal Health (CAH) have performed compared to their sector so far this year.

Yahoo | November 23, 2023

Cardinal Health (CAH) Hits 52-Week High: What's Aiding It?

Investors are optimistic about Cardinal Health's (CAH) diversified product portfolio.

Yahoo | November 23, 2023

Should Value Investors Buy Cardinal Health (CAH) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Yahoo | November 23, 2023

Why You Should Add DaVita (DVA) Stock to Your Portfolio

DaVita's (DVA) strength in its DaVita Kidney Care raises optimism about the stock.

Yahoo | November 22, 2023

Nevro's (NVRO) New Data Supports SCS Therapy for NSRBP Treatment

Nevro's (NVRO) latest 24-month data demonstrates the benefits of high-frequency 10 kHz SCS therapy for lasting pain relief, enhanced function, quality of life and reduced opioid dependency.

Yahoo | November 21, 2023

FDA concerned Cardinal Health failed to mitigate risk of incompatible syringes

Days after posting the Class 1 recall notice, the FDA said changes made to certain syringes could lead to overdose, underdose, or delays in therapy or alarms.

Yahoo | November 21, 2023

UPDATE 2-FDA warns against using Cardinal's syringes

The U.S. Food and Drug Administration on Monday warned healthcare providers and facilities not to use Cardinal Health's Monoject syringes with patient-controlled pain management pumps and syringe pumps. The regulator's warning comes after Cardinal Health initiated a recall for its Monoject syringes due to incompatibility concerns with syringe pumps. Monoject syringes are used to inject into or withdraw fluids from the body while patient-controlled analgesia, or pain management pumps, are used to treat different kinds of pain by transferring medications intravenously.

Yahoo | November 20, 2023

Why You Should Add Integer Holdings (ITGR) to Your Portfolio

Integer Holdings' (ITGR) research and product development activities and a solid foothold in the broader MedTech space raise optimism about the stock.

Yahoo | November 20, 2023

Here's Why You Should Retain CONMED (CNMD) Stock for Now

CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.

Yahoo | November 16, 2023 featured highlights Cboe Global, Parker-Hannifin, Microsoft, FedEx and Cardinal Health

Cboe Global, Parker-Hannifin, Microsoft, FedEx and Cardinal Health have been highlighted in this Screen of The Week article.

Yahoo | November 16, 2023

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!